Daniel R. Tereau
Net Worth

Last updated:

What is Daniel R. Tereau net worth?

The estimated net worth of Mr. Daniel R. Tereau is at least $17,930,765 as of 20 Mar 2023. He has earned $4,790,765 from insider trading and has received compensation worth at least $13,140,000 in PerkinElmer, Inc..

What is the salary of Daniel R. Tereau?

Mr. Daniel R. Tereau salary is $1,460,000 per year as Senior Vice President of Strategy & Bus. Devel. in PerkinElmer, Inc..

How old is Daniel R. Tereau?

Mr. Daniel R. Tereau is 57 years old, born in 1968.

What stocks does Daniel R. Tereau currently own?

As insider, Mr. Daniel R. Tereau owns shares in one company:

Company Title Shares Price per share Total value
PerkinElmer, Inc. (PKI) Senior Vice President of Strategy & Bus. Devel. 11,611 $0 $0

What does PerkinElmer, Inc. do?

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Daniel R. Tereau insider trading

PerkinElmer, Inc.

Mr. Daniel R. Tereau has made 28 insider trades between 2016-2023, according to the Form 4 filled with the SEC. Most recently he sold 5,304 units of PKI stock worth $657,749 on 20 Mar 2023.

The largest trade he's ever made was exercising 18,866 units of PKI stock on 12 Sep 2016. As of 20 Mar 2023 he still owns at least 11,611 units of PKI stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 5,304 $124.01 $657,749
Sale
Common Stock 15 $121.69 $1,825
Option
Common Stock 3,750 $52.65 $197,438
Sale
Common Stock 300 $124.79 $37,437
Sale
Common Stock 5,122 $123.37 $631,901
Option
NQ Stock Option (right to buy) 3,750 $52.65 $197,438
Option
NQ Stock Option (right to buy) 5,700 $52.65 $300,105
Option
Common Stock 5,700 $52.65 $300,105
Sale
Common Stock 5,700 $145.14 $827,298
Sale
Common Stock 300 $169.89 $50,967
Sale
Common Stock 1,100 $163.6 $179,960
Option
NQ Stock Option (right to buy) 6,696 $41.8 $279,893
Sale
Common Stock 1,700 $164.5 $279,650
Sale
Common Stock 800 $166.51 $133,208
Sale
Common Stock 1,391 $169.13 $235,260
Option
Common Stock 6,696 $41.8 $279,893
Sale
Common Stock 600 $167.86 $100,716
Sale
Common Stock 805 $162.35 $130,692
Sale
Common Stock 200 $192.18 $38,436
Option
NQ Stock Option (right to buy) 3,546 $46.26 $164,020
Option
Common Stock 3,546 $46.26 $164,020
Sale
Common Stock 928 $187.4 $173,907
Sale
Common Stock 920 $188.51 $173,429
Sale
Common Stock 598 $190.73 $114,057
Sale
Common Stock 900 $191.48 $172,332
Sale
Common Stock 2,047 N/A N/A
Option
NQ Stock Option (right to buy) 2,047 N/A N/A
Option
Common Stock 2,047 N/A N/A
Sale
Common Stock 4,094 $81.29 $332,801
Option
Common Stock 4,094 $81.29 $332,801
Option
NQ Stock Option (right to buy) 4,094 N/A N/A
Sale
Common Stock 5,452 $95.22 $519,139
Option
NQ Stock Option (right to buy) 3,242 $43.74 $141,789
Option
Common Stock 3,242 N/A N/A
Sale
Common Stock 1,200 N/A N/A
Sale
Common Stock 3,308 N/A N/A
Option
Common Stock 3,308 N/A N/A
Option
NQ Stock Option (right to buy) 3,308 N/A N/A
Sale
Common Stock 1,156 N/A N/A
Option
Common Stock 5,001 N/A N/A
Option
NQ Stock Option (right to buy) 5,001 N/A N/A
Sale
Common Stock 5,001 N/A N/A
Sale
Common Stock 524 N/A N/A
Sale
Common Stock 3,545 N/A N/A
Option
NQ Stock Option (right to buy) 3,545 N/A N/A
Option
Common Stock 3,545 N/A N/A
Option
NQ Stock Option (right to buy) 18,342 N/A N/A
Sale
Common Stock 18,866 N/A N/A
Option
Common Stock 18,342 $45 $825,298
Option
Common Stock 18,342 N/A N/A
Option
NQ Stock Option (right to buy) 18,342 $30 $550,205
Sale
Common Stock 2,158 N/A N/A

PerkinElmer key executives

PerkinElmer, Inc. executives and other stock owners filed with the SEC: